CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Baltimore, Maryland, United States and 38 other locations
Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...
Phase 2
Baltimore, Maryland, United States
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Bethesda, Maryland, United States and 22 other locations
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...
Alexandria, Virginia, United States and 5 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Baltimore, Maryland, United States and 34 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
Baltimore, Maryland, United States and 22 other locations
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...
Phase 1
Towson, Maryland, United States and 24 other locations
This study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy. Pa...
Phase 2
Baltimore, Maryland, United States and 4 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Fairfax, Virginia, United States and 55 other locations
The primary objective of this study is to compare the progression free survival (PFS) of patients with metastatic castration-resistant prostate...
Phase 2
Baltimore, Maryland, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal